JP2013504603A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2013504603A5 JP2013504603A5 JP2012529062A JP2012529062A JP2013504603A5 JP 2013504603 A5 JP2013504603 A5 JP 2013504603A5 JP 2012529062 A JP2012529062 A JP 2012529062A JP 2012529062 A JP2012529062 A JP 2012529062A JP 2013504603 A5 JP2013504603 A5 JP 2013504603A5
- Authority
- JP
- Japan
- Prior art keywords
- csf
- antibody
- cns
- use according
- composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US24250309P | 2009-09-15 | 2009-09-15 | |
| US61/242,503 | 2009-09-15 | ||
| PCT/AU2010/001191 WO2011032204A1 (en) | 2009-09-15 | 2010-09-14 | Treatment of neurological conditions |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015109380A Division JP2015187135A (ja) | 2009-09-15 | 2015-05-29 | 神経疾患の処置方法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2013504603A JP2013504603A (ja) | 2013-02-07 |
| JP2013504603A5 true JP2013504603A5 (enExample) | 2013-10-10 |
| JP5785550B2 JP5785550B2 (ja) | 2015-09-30 |
Family
ID=43757935
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2012529062A Expired - Fee Related JP5785550B2 (ja) | 2009-09-15 | 2010-09-14 | 神経疾患の処置方法 |
| JP2015109380A Pending JP2015187135A (ja) | 2009-09-15 | 2015-05-29 | 神経疾患の処置方法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015109380A Pending JP2015187135A (ja) | 2009-09-15 | 2015-05-29 | 神経疾患の処置方法 |
Country Status (11)
| Country | Link |
|---|---|
| US (2) | US9364534B2 (enExample) |
| EP (1) | EP2477656B1 (enExample) |
| JP (2) | JP5785550B2 (enExample) |
| KR (1) | KR101750426B1 (enExample) |
| CN (1) | CN102630167B (enExample) |
| AU (1) | AU2010295223B2 (enExample) |
| CA (1) | CA2773552C (enExample) |
| DK (1) | DK2477656T3 (enExample) |
| ES (1) | ES2623802T3 (enExample) |
| PL (1) | PL2477656T3 (enExample) |
| WO (1) | WO2011032204A1 (enExample) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20110117092A1 (en) * | 2009-10-20 | 2011-05-19 | The Regents Of The University Of Michigan | Compositions and methods for inhibiting g-csfr |
| BR112013031943B1 (pt) * | 2011-06-13 | 2021-10-13 | Csl Limited | Composição que compreende proteínas e anticorpos contra g-csfr |
| GB201401465D0 (en) * | 2014-01-29 | 2014-03-12 | Roach Arthur H | Use of cladribine for treating autoimmune inflammatory disease |
| ES2939461T3 (es) | 2017-11-29 | 2023-04-24 | Csl Ltd | Método para tratar o prevenir la lesión por isquemia-reperfusión |
| WO2019178645A1 (en) | 2018-03-23 | 2019-09-26 | Csl Limited | Method of treating asthma |
| WO2019226550A1 (en) * | 2018-05-21 | 2019-11-28 | CHS Pharma Inc. | Granulocyte colony-stimulating factor (gcsf) gene therapy for treating neurological diseases |
| US20220220209A1 (en) * | 2018-12-04 | 2022-07-14 | CSL Innovation Pty Ltd | Method of treating neutrophilic conditions |
| WO2025007195A1 (en) | 2023-07-05 | 2025-01-09 | CSL Innovation Pty Ltd | Methods of treating or preventing a complication of sickle cell disease |
| WO2025217678A1 (en) * | 2024-04-15 | 2025-10-23 | CSL Innovation Pty Ltd | Methods of treating or delaying progression or hindering development of a neutrophil-associated condition |
Family Cites Families (31)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4399216A (en) | 1980-02-25 | 1983-08-16 | The Trustees Of Columbia University | Processes for inserting DNA into eucaryotic cells and for producing proteinaceous materials |
| US4816567A (en) | 1983-04-08 | 1989-03-28 | Genentech, Inc. | Recombinant immunoglobin preparations |
| US4740461A (en) | 1983-12-27 | 1988-04-26 | Genetics Institute, Inc. | Vectors and methods for transformation of eucaryotic cells |
| DE3668186D1 (de) | 1985-04-01 | 1990-02-15 | Celltech Ltd | Transformierte myeloma-zell-linie und dieselbe verwendendes verfahren zur expression eines gens, das ein eukaryontisches polypeptid kodiert. |
| GB8601597D0 (en) | 1986-01-23 | 1986-02-26 | Wilson R H | Nucleotide sequences |
| US4959455A (en) | 1986-07-14 | 1990-09-25 | Genetics Institute, Inc. | Primate hematopoietic growth factors IL-3 and pharmaceutical compositions |
| US4946778A (en) | 1987-09-21 | 1990-08-07 | Genex Corporation | Single polypeptide chain binding molecules |
| US4912040A (en) | 1986-11-14 | 1990-03-27 | Genetics Institute, Inc. | Eucaryotic expression system |
| GB8717430D0 (en) | 1987-07-23 | 1987-08-26 | Celltech Ltd | Recombinant dna product |
| US5476996A (en) | 1988-06-14 | 1995-12-19 | Lidak Pharmaceuticals | Human immune system in non-human animal |
| US5223409A (en) | 1988-09-02 | 1993-06-29 | Protein Engineering Corp. | Directed evolution of novel binding proteins |
| IE66494B1 (en) | 1989-09-26 | 1996-01-10 | Immunex Corp | Granulocyte-colony stimulating factor receptors |
| US6150584A (en) | 1990-01-12 | 2000-11-21 | Abgenix, Inc. | Human antibodies derived from immunized xenomice |
| US6673986B1 (en) | 1990-01-12 | 2004-01-06 | Abgenix, Inc. | Generation of xenogeneic antibodies |
| US6075181A (en) | 1990-01-12 | 2000-06-13 | Abgenix, Inc. | Human antibodies derived from immunized xenomice |
| ES2087997T3 (es) | 1990-01-12 | 1996-08-01 | Cell Genesys Inc | Generacion de anticuerpos xenogenicos. |
| US5427908A (en) | 1990-05-01 | 1995-06-27 | Affymax Technologies N.V. | Recombinant library screening methods |
| GB9015198D0 (en) | 1990-07-10 | 1990-08-29 | Brien Caroline J O | Binding substance |
| US6172197B1 (en) | 1991-07-10 | 2001-01-09 | Medical Research Council | Methods for producing members of specific binding pairs |
| ATE463573T1 (de) | 1991-12-02 | 2010-04-15 | Medimmune Ltd | Herstellung von autoantikörpern auf phagenoberflächen ausgehend von antikörpersegmentbibliotheken |
| JP2002503951A (ja) * | 1996-05-07 | 2002-02-05 | ミレニアム ファーマシューティカルズ インク． | ニューロタクチンおよびその使用 |
| DE60135732D1 (de) * | 2000-02-28 | 2008-10-23 | Univ British Columbia | Topoisomerasehemmern zur behandlung von chirurgischen verklebungen |
| US7108852B2 (en) * | 2000-03-20 | 2006-09-19 | Warner-Lambert Company Llc | Methods of treating inflammation using antibodies to M-CSF |
| EP1401410A4 (en) * | 2001-03-30 | 2009-03-04 | Philadelphia Health & Educatio | IMMUNOMODULATION AND EFFECT ON CELL PROCESSES INVOLVING RECEPTORS OF THE SEROTONIN FAMILY |
| NZ538421A (en) * | 2002-08-23 | 2008-08-29 | Inst Medical W & E Hall | A method of treatment and prophylaxis |
| RU2369636C2 (ru) * | 2003-05-23 | 2009-10-10 | Уайт | Лиганд gitr и связанные с лигандом gitr молекулы и антитела и варианты их применения |
| WO2005121174A2 (en) * | 2004-06-04 | 2005-12-22 | Five Prime Therapeutics, Inc. | Novel g-csf polypeptides, polynucleotides, modulators thereof, and methods of use |
| US7612181B2 (en) * | 2005-08-19 | 2009-11-03 | Abbott Laboratories | Dual variable domain immunoglobulin and uses thereof |
| EP2046830B1 (en) * | 2006-07-06 | 2011-06-15 | Merck Serono SA | Csf3r polypeptides and uses thereof |
| PL2056858T3 (pl) * | 2006-08-11 | 2015-01-30 | Csl Ltd | Leczenie stanów chorobowych płuc |
| WO2008125903A2 (en) * | 2006-12-12 | 2008-10-23 | Chaim Sheba Medical Center | Method of inhibiting an undesired immune response |
-
2010
- 2010-09-14 CA CA2773552A patent/CA2773552C/en active Active
- 2010-09-14 WO PCT/AU2010/001191 patent/WO2011032204A1/en not_active Ceased
- 2010-09-14 DK DK10816462.5T patent/DK2477656T3/en active
- 2010-09-14 AU AU2010295223A patent/AU2010295223B2/en not_active Ceased
- 2010-09-14 JP JP2012529062A patent/JP5785550B2/ja not_active Expired - Fee Related
- 2010-09-14 US US12/881,293 patent/US9364534B2/en active Active
- 2010-09-14 PL PL10816462T patent/PL2477656T3/pl unknown
- 2010-09-14 KR KR1020127008842A patent/KR101750426B1/ko active Active
- 2010-09-14 CN CN201080048357.7A patent/CN102630167B/zh not_active Expired - Fee Related
- 2010-09-14 EP EP10816462.5A patent/EP2477656B1/en active Active
- 2010-09-14 ES ES10816462.5T patent/ES2623802T3/es active Active
-
2014
- 2014-03-24 US US14/223,315 patent/US9352038B2/en active Active
-
2015
- 2015-05-29 JP JP2015109380A patent/JP2015187135A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2013504603A5 (enExample) | ||
| Yang et al. | CXCL12-CXCR4/CXCR7 axis in cancer: from mechanisms to clinical applications | |
| JP7395483B2 (ja) | ｍＲＮＡの細胞内送達のためのペプチドおよびナノ粒子 | |
| JP7579589B2 (ja) | Ｒａｎタンパク質関連神経学的疾患を処置するための方法 | |
| US10479997B2 (en) | Compositions and methods for diagnosis and treatment of prostate cancer | |
| EP2513146B1 (en) | Antibodies against ror1 capable of inducing cell death of cll | |
| US20180010132A1 (en) | Inhibition of prmt5 to treat mtap-deficiency-related diseases | |
| CN112654350A (zh) | 使用nlrp3拮抗剂治疗对tnf抑制剂有抗性的受试者或针对所述患者选择治疗的方法 | |
| JP2013537418A5 (enExample) | ||
| JP2014076062A5 (enExample) | ||
| JP2017113019A5 (enExample) | ||
| JP2006525796A5 (enExample) | ||
| JP2012521217A5 (enExample) | ||
| US20250295809A1 (en) | Compositions and methods for the treatment of her2 positive cancer | |
| TWI500629B (zh) | 介白素－６抗體及其用途 | |
| JP7514846B2 (ja) | 肝毒性の治療 | |
| JP2010500291A5 (enExample) | ||
| JP2010526153A5 (enExample) | ||
| JP2015522264A5 (enExample) | ||
| AU2018314236B2 (en) | RNA aptamers against transferrin receptor (TfR) | |
| JP2012505657A5 (enExample) | ||
| JP2020511493A (ja) | セマフォリン−４ｄ抗体とエピジェネティック調節剤の組み合わせを用いたがんの処置方法 | |
| JP2018529661A5 (enExample) | ||
| JP2023520103A (ja) | ＦｏｘＰ３発現を阻害する修飾されたアンチセンスオリゴヌクレオチド | |
| CN117752784A (zh) | Wnt抑制剂和抗PD-1抗体分子组合的给药方案 |